Swiss Re’s Sprackling: Medical Advances Reshape Mortality Trends, Risk Strategies

Neil Sprackling, CEO of Life and Health Re US at Swiss Re, explores how breakthroughs in personalized medicine, metabolic health and early disease detection are transforming longevity expectations and underwriting in the insurance industry.